Alexander Labrunerie & Co’s Amgen AMGN Stock Holding History

Alexander Labrunerie & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$306K	Hold	871	–	–	0.11%	92
2025 Q4	$285K	Hold	871	–	–	0.1%	92
2025 Q3	$246K	Sell	871 -15	-2%	-$4.35K	0.09%	94
2025 Q2	$247K	Sell	886 -73	-8%	-$20.7K	0.1%	94
2025 Q1	$299K	Buy	959 +21	+2%	+$6.2K	0.13%	82
2024 Q4	$244K	Sell	938 -34	-3%	-$10.1K	0.11%	89
2024 Q3	$313K	Sell	972 -30	-3%	-$9.81K	0.14%	76
2024 Q2	$313K	Buy	1,002 +74	+8%	+$21.7K	0.17%	66
2024 Q1	$264K	Buy	+928	New	+$272K	0.15%	74

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alexander Labrunerie & Co's AMGN Position: Q1 2026 in Review

Alexander Labrunerie & Co held its Amgen (AMGN) position steady in Q1 2026 at 871 shares worth $306K. The position accounts for 0.11% of the portfolio, ranked #92.

Alexander Labrunerie & Co first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. The position peaked at $313K in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Alexander Labrunerie & Co held 871 shares of Amgen worth $306K as of Q1 2026.
Alexander Labrunerie & Co left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.11% of Alexander Labrunerie & Co's portfolio in Q1 2026, its #92 holding.
Alexander Labrunerie & Co first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
Alexander Labrunerie & Co's Amgen position peaked at $313K in Q3 2024.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q1 2026, filed 18 May 2026.